<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Gilead to Test Remdesivir Delivered Through Inhalation
Image Overlay - Gilead to Test Remdesivir Delivered Through Inhalation

Gilead to Test Remdesivir Delivered Through Inhalation

July 3, 2020

Gilead to Test Remdesivir Delivered Through Inhalation

Gilead will begin testing an inhaled version of their leading COVID-19 treatment, Remdesivir. It is currently administered to patients intravenously in a hospital setting, though delivery via a nebulizer is decidedly more patient-centric. Regardless of dosage form, Yourway has the means to transport, store, and ship even the most sensitive clinical trial samples globally.

 Back to Index
Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?